Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB diagnosis news

Show

From To
Extrapulmonary tuberculosis - A challenging diagnosis

For World TB Day 2013, ECDC is launching a video documentary that focuses on extrapulmonary tuberculosis (TB). Two patient stories illustrate how difficult the diagnosis of extrapulmonary TB can be before proper treatment and care can start.

Published
20 March 2013
From
ECDC video
New ECDC/WHO Euro report: One in five TB patients has extrapulmonary tuberculosis

In the European Union, one in five tuberculosis patients has extrapulmonary TB and unlike pulmonary TB, this form of the disease does not show a downward trend. Extrapulmonary TB is rarely infectious but contributes significantly to TB-related morbidity and can cause complications, lifelong sequelae and disabilities.

Published
20 March 2013
From
ECDC
Sluggish response risks squandering historic opportunity to tackle global drug-resistant tuberculosis

If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB rates will continue to increase worldwide and a historic opportunity to improve abysmal cure rates will have been squandered, medical humanitarian organisation Médecins Sans Frontières (MSF) warned today.

Published
20 March 2013
From
MSF
Alere to Develop Simple, Affordable Point-of-Care Nucleic Acid Test for Tuberculosis & Expand Manufacturing for POC HIV Viral Load Platform

Alere Inc. announced that it has been awarded a grant of up to $21.6 million and debt financing of up to $20.6 million from the Bill & Melinda Gates Foundation to support development of a point-of-care nucleic acid test for tuberculosis and to expand production facilities for this test and for a point-of-care viral load test.

Published
02 March 2013
From
Alere
Information Note on the use of Xpert MTB/RIF for detection of TB among people living with HIV

The document describes the early evidence on use of the tool – including research findings and modeling results – and provides algorithms for the management of people living with HIV and with presumptive TB.

Published
18 February 2013
From
WHO
Cochrane review gives thumbs up to GeneXpert test for detection of MDR-TB

This systematic review published in The Cochrane Library provides timely advice to clinicians and policymakers in countries where TB is a major public health problem.

Published
01 February 2013
From
Citizen News Service
Steep fall in incidence of TB among HIV-positive heterosexuals in the UK

Incidence of tuberculosis (TB) among HIV-positive heterosexual people in England and Wales declined significantly between 2002 and 2010, investigators report in the online edition of AIDS. The

Published
15 January 2013
By
Michael Carter
United States government announces $11 million in additional support for rapid TB test in 14 countries

Countries receiving the rapid tests are: Côte d'Ivoire, DRC, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Nigeria, Swaziland, Tanzania, Uganda, Zambia, Zimbabwe and Burma.

Published
06 December 2012
From
PEPFAR press release
Xpert MTB/RIF for those with HIV; the importance of considering equity

Anna Vassall from the London School of Hygiene and Tropical Medicine discusses a recently published analysis of the potential health and economic consequences of implementing Xpert MTB/RIF in southern Africa.

Published
23 November 2012
From
PLoS Blogs (blog)
Xpert test for TB could help prevent deaths in southern Africa, but at substantial cost

A rapid test for tuberculosis (TB) could help to reduce TB deaths, improve TB treatment, and also offer reasonably good value for money if introduced in southern Africa, an area that has high rates of HIV and a type of TB that is resistant to some drugs (multi-drug resistant TB), according to a study published in this week's PLOS Medicine.

Published
21 November 2012
From
Eurekalert Inf Dis
← First12345...9Next →

Filter by country